Ruplekha Choudhurie

Ruplekha Choudhurie is a Research Director with Everest Group’s R&D and Innovation Excellence (RDIE) practice, specializing in technology intelligence and strategic foresight consulting. She focuses on emerging and disruptive technologies in life sciences and biotechnology, helping clients make confident decisions around R&D strategies and innovation. Her expertise spans advanced therapeutic modalities ( CGT, mRNA), next-generation drug discovery, clinical diagnostics, and enabling technologies that are transforming biopharma R&D. She previously worked with Frost & Sullivan and the Children’s Hospital of Philadelphia. She holds an MS in Biotechnology from the University of Pennsylvania and a B.Tech from Anna University, India.